Claim 70% Off TipRanks This Holiday Season
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An update from Haleon PLC Sponsored ADR ( (HLN) ) is now available.
On April 4, 2025, Haleon PLC announced the availability of documents for its 2025 Annual General Meeting (AGM), scheduled to be held virtually on May 28, 2025. The AGM will be broadcast from the company’s London offices, and shareholders can access the Notice of the AGM, Form of Proxy, and AGM Voting Instruction Card on Haleon’s website. This announcement underscores Haleon’s commitment to maintaining transparency and engagement with its shareholders, reflecting its strategic focus on leveraging digital channels for stakeholder communication.
More about Haleon PLC Sponsored ADR
Haleon PLC is a global leader in consumer health, focusing on delivering better everyday health with humanity. The company offers a diverse product portfolio across five major categories: Oral Health, Pain Relief, Respiratory Health, Digestive Health, and Vitamins, Minerals, and Supplements (VMS). Haleon is known for its long-standing brands such as Advil, Sensodyne, Panadol, Voltaren, Theraflu, Otrivin, Polident, parodontax, and Centrum, which are built on trusted science and innovation.
YTD Price Performance: 10.70%
Average Trading Volume: 10,587,699
Technical Sentiment Signal: Strong Sell
Current Market Cap: $46.7B
See more data about HLN stock on TipRanks’ Stock Analysis page.